Shay Capital »

Aerovate Therapeutics shares owned by Shay Capital

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Shay Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $727k 25k 29.57

More positions owned by Shay Capital

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alibaba Group Hldg Sponsored Ads (BABA)
Purecycle Technologies (PCT)
Ishares Silver Tr Ishares (SLV)
Datadog Cl A Com (DDOG)
Viking Therapeutics (VKTX)
Golar Lng SHS (GLNG)
Endeavor Group Hldgs Cl A Com (EDR)
Tillys Cl A (TLYS)
Baidu Spon Adr Rep A (BIDU)
Genworth Finl Com Cl A (GNW)
Snowflake Cl A (SNOW)
Mbia (MBI)
Turtle Beach Corp Com New (HEAR)
Advanced Micro Devices (AMD)

View all positions for Shay Capital

Top funds holding Aerovate Therapeutics

RA Capital Management
Sofinnova Ventures
TCG Crossover Management
Atlas Venture Life Science Advisors
Baker Bros. Advisors
Frazier Life Sciences Management
Cormorant Asset Management
Dr. Jeffrey R. Jay, M.D.
Driehaus Capital Management
BlackRock
Vanguard Group
OrbiMed Advisors
FMR
Eventide Asset Management
Octagon Capital Advisors

View all funds holding Aerovate Therapeutics